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Abstract – This paper presents a systematic review of the dental literature that
was carried out to investigate whether the regular use of fluoride supplements in
non-fluoridated communities during the period of tooth development increases
the risk of dental fluorosis. A MEDLINE search was organized for all documents
published, in English, between January 1966 and September 1997 using the
following key words: fluorosis, dental, fluoride, fluoride supplement or supple-
ments, drop or drops, and tablet or tablets. Twenty-four studies that assessed the
development of dental fluorosis in children who had used fluoride supplements
earlier in their life were included in this review. Of the 24 studies, 10 were cross-
sectional/case control studies and four were follow-up studies. These studies had
data that allowed a quantitative estimation of the risk of developing dental fluo-
rosis in users of fluoride supplements. The other 10 studies were excluded because
they either did not present enough data or had other methodological problems. Key words: fluoride supplements; fluorosis;
meta-analysisA qualitative review of the studies found a consistent and strong association be-
tween the use of fluoride supplements and dental fluorosis. The meta-analyses Amid I. Ismail, Department of Cariology,
Restorative Sciences, and Endodontics,of the cross-sectional/case-control studies estimated that the odds ratio of dental
School of Dentistry, The University offluorosis in users of fluoride supplements compared with non-users ranged be-
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tween 2.4 and 2.6. The meta-analyses of the follow-up studies estimated that the Ann Arbor, Michigan 48109–1078, USA
relative risk in long-term users was between 5.5 and 12.2. This review confirmed Tel: π1 734 647 9190. Fax: π1 734 936 1597
E-mail: ismailai/umich.eduthat in non-fluoridated communities the use of fluoride supplements during the
first 6 years of life is associated with a significant increase in the risk of develop- Accepted without peer review 9 November
ing dental fluorosis. 1998
The objective of this paper is to present a systemat-
ic review of the dental literature to answer the
following question: does the regular use of fluoride
supplements in non-fluoridated communities dur-
ing the period of tooth development increase the
risk of dental fluorosis?
In the absence of direct evidence from random-
ized clinical trials, harm from interventions, such as
fluoride products, should be determined following
the criteria described by Lilienfeld & Stolley (1).
Specifically, fluoride supplements are considered a
risk factor of dental fluorosis if the association be-
tween the use of supplements and fluorosis is
strong, consistent, and specific; has the correct tem-
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poral sequence of an exposure preceding the occur-
rence of disease; is dose-response dependent; and is
biologically plausible.
To assess the strength of the association between
the use of fluoride supplements and dental fluoro-
sis, measures such as relative risk (RR) or odds ra-
tios (OR) are used (1). The magnitude of these two
measures determines the strength of an association
between fluoride supplements and fluorosis. For
instance, if the value of RR is at least 2.0 (the prob-
ability of disease in the exposed group is two times
higher than the probability of disease in the unex-
posed group), then there is a possibility that the
association may be causal if the other criteria are
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met as well. An OR estimates the odds of disease
in the exposed group relative to the odds of disease
in the unexposed group.
In addition to the strength of an association,
consistency of an association refers to finding
similar trends in several well-designed studies.
Because recall error and confounding are associ-
ated with measuring the intake of fluoride during
the first 6 years of life, replication is a necessary
requirement for concluding that there is an asso-
ciation between the ingestion of fluoride supple-
ments and dental fluorosis. One problem encoun-
tered in evaluating the consistency of an associa-
tion is the diversity in the statistical significance
of the findings because of small sample sizes and
the different designs used in epidemiological
studies. To resolve this problem, meta-analytical
methods are used to aggregate data from dif-
ferent studies and provide a quantitative estimate
of the OR or RR (2). In a meta-analysis, a system-
atic review of the literature is conducted and
studies are included or excluded from the anal-
ysis depending on whether they meet the eligibil-
ity criteria for inclusion set by the reviewers. The
data are combined statistically to provide a quan-
titative estimate of the size of effect of exposure
and risk of disease (2).
The available evidence on dental fluorosis clearly
indicates that there is a temporal sequence between
exposure to fluoride during the period of tooth de-
velopment (0–7 years of life) and the development
of dental fluorosis (3–5). There is also some evi-
dence that a dose-response relationship exists be-
tween the ingestion of fluoride and occurrence of
dental fluorosis (6). Children who brushed their
teeth and ingested fluoride supplements had a sig-
nificantly higher risk of developing fluorosis (7)
than children who only brushed their teeth with
fluoridated dentifrices.
Regarding the biological plausibility of the asso-
ciation between fluoride supplements and dental
fluorosis, there is evidence that the presence of
fluoride in tissue fluids that surround the develop-
ing enamel organ causes several changes in the bio-
chemistry of ameloblasts and their metabolism,
and eventually the mineralization of enamel (8).
Fluoride causes the retention of proteins such as
amelogenins in the tooth structure leading to the
formation of hypomineralized enamel (8) that has a
different refraction index than sound non-fluorotic
enamel. As a result, light reflection through enamel




To answer the question posed at the beginning of
this paper, a systematic analysis of the dental litera-
ture and a meta-analysis were conducted to deter-
mine the strength of the association between fluo-
ride supplements and dental fluorosis. A MED-
LINE search was organized for all studies
published, in English, between January 1966 and
September 1997. The following key words were
used to search for all documents written in the
English literature: fluorosis, dental, fluoride, fluo-
ride supplement or supplements, drop or drops,
and tablet or tablets. A search for unpublished
studies was also carried out using contacts with re-
searchers in the field. Two unpublished studies
were located and one of them (which was subse-
quently published) was used in this review (per-
mission was not obtained for the second paper).
The studies identified by the search were classi-
fied into two groups. The first group included
cross-sectional/case-control studies where infor-
mation on use of fluoride supplements was ob-
tained from self-administered questionnaires or in-
terviews with parents. The second group included
follow-up studies where data on fluoride use were
available for a group of children and the investiga-
tors conducted an examination for presence of flu-
orosis at a later date. Ten cross-sectional/case-con-
trol and four follow-up studies were located with
enough data to allow for further quantitative anal-
ysis (Table 1 and Table 2).
A total of 10 studies were excluded. The reason
for the exclusion of each study is summarized in
Table 3. Most of the excluded studies did not pres-
ent enough data to allow inclusion in the meta-
analysis. Another reason for exclusion was the lack
of external validity of some of the studies that ei-
ther included a sample with very high prevalence
of fluorosis or had too few users of fluoride supple-
ments. In one clinical study of fluoride supple-
ments the children resided in areas where the fluo-
ride concentration in the water was higher than 0.6
mg/L (Table 3).
Evidence tables were prepared for each group of
studies. The evidence tables summarized informa-
tion on the authors, year of publication, method
of data collection and age of exposure to fluoride
supplements, groups of exposures included in the
study, number of children by group, prevalence of
fluorosis, odds ratios or relative risks, and 95% con-
fidence intervals (CI) (except for study by Pen-
drys & Katz [3] where 99% CI were presented).
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Table 1. Risk of fluorosis in users of fluoride supplements: cross-sectional/case-control studies
Method/age
Authors Year of exposure Groups n Prevalence Odds ratio 95% CI
De Liefde & 1985 Questionnaire 1. Non-F water 237 22.8%*
Herbison (10) 9 years of life 2. Up to 5–6 years of 82 28.1% 1.3 0.8–2.3
life
3. Continuous use up 156 49.4% 3.3 2.1–5.1
to 9 years of life
4. Fluoridated water 191 36.7% 2.0 1.3–3.0
Granath et al. 1985 Questionnaire Tablet users 49 28.6%1 2.4 0.9–5.9
(11) 0.25 mg F tablets Control group 69 14.5%
between 6 months
and 6 years
Pendrys & Katz 1989 Questionnaire 1. Not used TotalΩ850 NR2 1.01
(3) 850 cases and controls 2. Year 1 of life 1.4 0.6–3.0
3. Years 3–6 3.3 1.5–7.5
4. Year 1 and years 3–6 3.9 1.6–9.2
Bagramian et al. 1989 Questionnaire Daily vs irregular TotalΩ159 46.4%3 1.4 0.7–2.8
(12) 206 children 9 to 13 users 37.8%
years
Woolfolk et al. 1989 Questionnaire 1. Never 119 13.4%3
(13) 543 children aged 9 2. ∞regular 90 21.1% 1.7 0.8–3.6
to 13 years 3. Regular 170 32.4% 3.1 1.7–5.7
Riordan & 1991 Questionnaire 1. Little NR NR4 1.6 0.5–4.4
Banks (14) Exposure to 2. Medium 0.9 0.3–2.5
supplements between 3. Optimal 4.6 2.0–10.9
birth and 4 years
Clark et al. (15) 1994 Questionnaire 1. None 93 1%3
Ω6 years of life 2. ∞4 years 184 5% 4.8 0.6–38.4
3. 4 or more years 96 10% 10.7 1.3–85.3
4. Lifelong water 109 11% 11.4 1.5–89.3
fluoridation
Lalumandier & 1995 Questionnaire/ Daily fluoride 113 NR3 6.5 2.2–19.4
Rozier (16) interview supplement use vs ∞
113 patients exposed to daily
non-fluoridated water
Pendrys et al. 1996 Questionnaire 1. Not used vs use 111 NR2 1.3 0.8–2.2
(17) 460 cases and controls during year 1 of life 280 NR
2. Not used vs use 58 NR 2.3 1.1–4.7
during years 2–8 333 NR
Wang et al. (18) 1997 Questionnaire 1. Non-user 21 0%4
383 children 76% 2. Seldom 20 2%
used fluoride supple- 3. Periodically 85 18% 2.45 0.5–11.4
ments 4. Regularly 257 45% 7.45 1.7–32.6
* DDE (Developmental Defects of Enamel) (19): diffuse opacities.
1 Dean’s Fluorosis Index (20).
2 Fluorosis Risk Index (21): Classification I.
3 TSIF (Tooth Surface Index of Fluorosis) (22).
4 Thylstrup-Fejerskov Fluorosis Index (23).
5 Compared with those who ‘‘seldom’’ used fluoride supplements.
Meta-analysis
Any use of fluoride supplements
The first series of meta-analyses that was conduct-
ed included all potential users of fluoride supple-
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ments. The analysis included 10 cross-sectional/
case-control studies and four follow-up studies.
The summary odds ratios or relative risks (sum-
mary OR or RR) and 95% confidence intervals were
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obtained using the following three statistical
methods:
1) Mantel-Haenszel method: uses 2¿2 frequency
tables to estimate the summary OR and its stan-
dard error (2).
2) Generalized variance method: uses the calcu-
lated OR (or RR) and the lower bound of the 95%
confidence interval to obtain an estimate of the
standard error (2).
3) DerSimonian-Laird method: uses 2¿2 fre-
quency tables to estimate the summary OR or RR
and its standard error (9). No test of homogeneity
is available for this method (2).
The Mantel-Haenszel and the DerSimonian and
Laird methods require data from 2¿2 frequency
tables to estimate the summary measures (OR or
RR) and their standard errors. Twelve 2¿2 tables
from the 10 cross-sectional/case-control studies
and ten 2¿2 tables from the four follow-up studies
were created and used in the meta-analysis. The
generalized variance method uses the calculated
OR or RR and the lower bound of the 95% confi-
dence interval (2). For this method, 19 separate
Table 2. Risk of fluorosis in users of fluoride supplements: follow-up studies
Method/age Cumulative Relative
Authors Year of exposure Groups n incidence risk 95% CI
Aasenden & 1974 Non-randomized 1. No fluoride 93 4.3%*
Peebles (24) Non-representative 2. 0.5 NaF 0–3 years, 1.0 100 67% 15.6 5.9–41.0
No control for afterwards
confounding 3. Fluoridated water 92 32.6% 7.6 2.8–20.7
Non-fluoridated area
Holm & 1982 Interviews Age at start of use of
Andersson (25) Longitudinal study NaF tablets (months):
6 months to 6 years 1. 6 21 81%† 5.4 1.9–15.6
Fluorosis was assessed 2. 12 51 59% 3.9 1.4–11.4
at the age of 12 years 3. 24 8 38% 2.5 0.6–9.9
4. 36 6 33% 2.2 0.5–10.4
5. Sporadically 28 18% 1.2 0.3–4.4
6. Not 20 15% 1.0
Larsen et al. (26) 1985 70 children who Central incisors
received 0.5 mg F tablet/ 1. 2.5–4.4 years 20 15%† 4.2 0.9–19.3
day between 2.5 and 9.4 2. 4.5–9.4; no tablets 84 3.6%
years; 40 children with Lateral incisors
no tablets 1. 2.5–4.4 19 15.8% 4.3 0.9–19.7
Blind examinations 2. 4.5–9.4; no tablets 82 3.7%
Kalsbeek et al. (6) 1992 Dentists evaluated use 1. Not a user 55 7%†
of supplements between 2. Irregular user 125 10% 1.4 0.5–4.2
1.5 anf 6 years; fluorosis 3. Regular user 179 19% 2.6 1.0–7.0
was assessed at the age 4. Frequent user 61 36% 5.0 1.8–13.5
of 15 years
* Dean’s Fluorosis Index (20): very mild to moderate fluorosis.
† Thylstrup-Fejerskov Fluorosis Index (23).
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odds ratios from the cross-sectional/case-control
studies and 11 measures of relative risks were used.
Tests of homogeneity of variances for the Mantel-
Haenszel and the generalized variance method
were performed as described by Petitti (2).
Appropriate use of fluoride supplements
The meta-analyses were repeated by including
only the users of fluoride supplements who had
regularly used fluoride supplementation during at
least the first 6 years of life. This condition re-
stricted the number of studies included to seven




Cross-sectional/case-control studies: all users of
fluoride supplements
These studies are listed in chronological order in
Table 1. Children who used fluoride supplements
during the first several years of life had a signi-
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ficant increase in the risk of developing dental flu-
orosis. Eight studies found statistically positive as-
sociations between the use of fluoride supplements
and dental fluorosis (Table 1). The OR of develop-
ing fluorosis in users of fluoride supplements dur-
ing the first 8 years of life ranged from a low of 1.3
to a high of 10.7.
Follow-up studies: all users of fluoride supplements
These studies are listed in chronological order in
Table 2. The relative risk of developing fluorosis in
children who used fluoride supplements during
the first several years of life was highly significant
(RRΩ15.6 with 95% CIΩ5.9–41.0 [24] or RRΩ5.0
with 95% CIΩ1.8–13.5 [6]). One study found that
the earlier in life fluoride supplements were used
the higher the risk of developing fluorosis (25).
Table 3. List of excluded studies
Author Year Finding Reason for exclusion
Hennon et al. (27) 1977 A randomized clinical trial with significant loss The children in the study resided in area that
of subjects. Children who used 0.5 mg F had 0.6–0.8 mg/L fluoride in its drinking water
supplements between 0–3 years and 1.0 mg F
supplements between 3 and 6.5 years had
significantly higher incidence of fluorosis
compared with children who were on a placebo
Thylstrup et al. 1979 ‘‘A positive association between number of Statistics included in the paper were not
(28) tablets prescribed and dental fluorosis was found sufficient to estimate the risk of fluorosis
in erupted permanent teeth’’
Allmark et al. (29) 1982 No differences in fluorosis between children Not applicable to 0–6-year-old age group
who sucked 2.2 mg NaF tablets and those in the
control group. Program started at the age of 6
years
Wöltgens et al. (7) 1989 Daily fluoride intake before the age of 4 years Inadequate data were presented
may explain the high prevalence of ‘‘mottled’’
enamel
Kumar et al. (30) 1989 Daily use of fluoride tablets increased the risk Inadequate data were presented
of fluorosis
Ismail et al. (31) 1990 ‘‘The use of fluoride supplements was Data were not presented separately for the
significantly associated with fluorosis’’. Odds fluoridated and non-fluoridated communities
ratioΩ1.8 (1.5–2.1)
Holt et al. (32) 1990 ‘‘There was a statistically insignificant, but Only summary data were presented. The
consistent, trend for the prevalence of opacities prevalence of fluorosis in the children who did
to increase with increasing duration of use of not use fluoride supplements was ±60%
fluoride supplements’’
Stephen et al. (33) 1991 No significant difference between children who Inadequate data were presented on fluorosis
used fluoride supplement at birth and those who and use of fluoride supplements
had started at the age of 7 years
D’Hoore & Van 1992 Children who used fluoride tablets exhibited Inadequate data were presented on fluorosis
Nieuwenhuysen mild fluorosis more frequently than non-users. and use of fluoride tablets
(34) Odds ratioΩ9.6
Riordan (35) 1993 Supplement use did not afftect caries or Fluoride supplements were used by only 4.6%
fluorosis prevalences of the children in the study
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Children who started using fluoride supplements
at the age of 6 months had 5.4 times higher inci-
dence of dental fluorosis than children who did not
use supplements at all (25). The use of fluoride
supplements during the first year of life is associ-
ated with a statistically significant increase in risk
of fluorosis (Table 2). Children who used supple-
ments starting at the age of 24 months had an
increased risk compared to non-users, but the RR
was not statistically significant because of the small
sample size (25). In another small study, children
who used fluoride supplements between 2.5 and
4.4 years of their lives had a higher relative risk
(4.2) than children who either did not use supple-
ments or used them after the age of 4.4 years (26).
This finding was not statistically significant be-
cause of the small sample size (95% CI: 0.9–19.3).
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Table 4. Findings from the meta-analysis that included all users of fluoride supplements
Test of
Number of Summary homogeneity
Study type 2¿2 tables Methods OR or RR 95% CI (c2 value, P-value)
Cross-sectional/ 12 Mantel-Haenszel 2.3 (1.5, 3.4) (12.1, 0.4)
case control 19 Generalized variance 2.2 (1.9, 2.6) (34.2, 0.01)
12 DerSimonian-Laird 2.1 (1.7, 2.5) NA
Follow-up* 10 Mantel-Haenszel 6.6 (2.9, 15.2) (15.2, 0.08)
11 Generalized variance 1.3 (2.6, 5.3) (16.6, 0.08)
10 DerSimonian-Laird 3.5 (2.3, 5.5) NA
NAΩnot applicable.
* Generalized variance estimate, confidence interval and test of homogeneity are based on the RR.
Meta-analysis
Cross-sectional/case-control studies: all users of
fluoride supplements
Table 4 presents the findings of several meta-anal-
yses using the previously described methods. The
Mantel-Haenszel method estimated that the sum-
mary OR for the association between any use of
fluoride supplements and dental fluorosis is about
2.3 (95% confidence interval: 1.5–3.4). The DerSi-
monian-Laird and generalized variance methods
gave a summary OR of 2.1 (1.7–2.5) and 2.2 (1.9–
2.6), respectively. Because of the lack of homogene-
ity of variances among the studies, the results of
the Mantel-Haenszel method, which assumes equ-
ality of the variances of the odds ratios, may be
invalid. The random-effect method that is the basis
for the DerSimonian-Laird algorithm is preferred
in this case. However, the DerSimonian-Laird
method gives higher weight to small studies and
hence, it may emphasize poor evidence at the ex-
pense of good evidence (2). Overall, the meta-anal-
yses found that the summary OR on average is be-
tween 2.1 and 2.3, indicating that children who use
Table 5. Findings from the meta-analysis that included appropriate users of fluoride supplements (during at least the first
6 years of life)
Test of
Number of Summary homogeneity
Study type 2¿2 tables Methods OR or RR 95% CI (c2 value, P-value)
Cross-sectional/ 7 Mantel-Haenszel 2.6 (1.7, 4.1) (6.1, 0.4)
case control 12 Generalized variance 2.6 (2.1, 3.2) (23.9, 0.01)
7 DerSimonian-Laird 2.4 (1.9, 3.1) NA
Follow-up* 5 Mantel-Haenszel 12.2 (4.9, 30.4) (7.2, 0.13)
5 Generalized variance 5.6 (3.4, 9.4) (11.8, 0.02)
5 DerSimonian-Laird 5.5 (2.7, 11.4) NA
NAΩnot applicable.
* Generalized variance estimate, confidence interval and test of homogeneity are based on the RR.
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fluoride supplements have two times higher odds
of developing fluorosis than those who never used
fluoride supplements.
Follow-up studies: all users of fluoride supplements
For the follow-up studies, the summary RR ranged
between 1.3 (2.6–5.3) for the generalized variance
method and 6.6 (2.9–15.2) for the Mantel-Haenszel
method. The DerSimonian-Laird method estimated
that the summary RR was 3.5 (2.3–5.5). The follow-
up studies showed a stronger association between
any use of fluoride supplements and dental fluo-
rosis because the determination of exposure to
fluoride supplements was based on records or de-
tailed interviews rather than recall by parents or
self-administered questionnaires.
Appropriate use of fluoride supplements
When the meta-analyses were restricted to children
who had regularly used fluoride supplements dur-
ing at least the first 6 years of life (Table 5), the
summary OR were between 2.4 and 2.6 (Table 5).
For the follow-up studies, the DerSimonian-Laird
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method estimated a summary OR of 5.5 (2.7–11.4)
(Table 5), which is higher than the 3.5 reported in
the previous analysis (Table 4).
Discussion
This qualitative and quantitative review found that
the use of fluoride supplements increases the risk of
developing dental fluorosis by at least two times.
Most of the fluorosis found in the studies included
in this paper was of the very mild to mild type. The
association between fluoride supplements and den-
tal fluorosis is strong and consistent. There is a clear
temporal sequence in that infants and toddlers who
used fluoride supplements had a higher prevalence
of fluorosis in their permanent teeth than those who
did not use fluoride supplements. This finding was
recently confirmed by an epidemiological study of a
population that was exposed to about 3.0 mg/L nat-
urally fluoridated water for a period of 7 years (5).
Children who were not born or were less than 1 year
old when the drinking water of the community was
switched from a low- to a high-fluoride source expe-
rienced the highest levels of fluorosis compared
with older children (5). The odds that a child who
had used the high fluoride water during the first
year of life developed dental fluorosis was 2.5 times
higher than those of children who drank the same
water after the age of 2 years (5).
The specificity of the association between dental
fluorosis and the use of fluoride supplements is dif-
ficult to establish from epidemiological studies that
rely on recall of past use of fluoride products.
There is evidence that the combined use of fluoride
supplements and toothbrushing with a fluoridated
dentifrice during the first year of life significantly
increases the odds of developing fluorosis (ORΩ
6.2) compared with toothbrushing alone (ORΩ1.5)
(4). Hence, fluoride supplements have at least an
additive effect on the risk of developing dental
fluorosis in infants and toddlers who brush their
teeth with fluoridated dentifrices.
In addition to the finding of this analysis there
are other issues that need to be considered when
prescribing supplements. The problem with getting
professionals to comply with the current dosage
schedules for use of fluoride supplements is an im-
portant factor to consider in assessing this vehicle
for delivery of fluoride. There is now consistent
evidence to support the observation that some
health professionals prescribe fluoride supple-
ments without taking into account the level of
fluoride in the drinking water (36).
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In addition, there are other sources of exposure
to fluoride during infancy that have not yet been
considered in the current guidelines for use of
fluoride supplements. The use of soy-based milk
formulae and tea raises the fluoride intake of some
infants to ‘‘near optimal levels’’ (37). Infants’ foods
and drinks may also contain enough fluoride to
provide the so called ‘‘optimal intake’’ (38). Con-
sidering these factors, it is imperative that new
guidelines for fluoride supplements either take the
total intake of fluoride of children into account or
consider their caries risk status before recommend-
ing fluoride supplements.
While this paper did not address the question of
the pre- and post-eruptive effects of fluoride on
caries prevention, the other papers presented at
this conference (39, 40) clearly show that fluoride
works best when available in low concentrations in
the oral environment for long periods during a day.
The topical effect of fluoride on development of
dental caries was documented over 50 years ago
by Klein (41) who found a decline of 40%–60% be-
tween 1943 and 1945 in dental caries incidence
among Japanese-American children who were
forced to live in a detention camp, during World
War II, that had a naturally fluoridated water (3.0
mg/L) compared with another group of Japanese-
American children who were located to a low-
fluoride camp. The effect of fluoride on protecting
newly erupting teeth was higher than the effect on
teeth that had erupted before the relocation to the
detention camps (41). These findings closely paral-
lel those reported in the water fluoridation studies
and experiments conducted in the 1940s and 1950s
(42).
Policy-makers should consider these factors
when making a decision on new recommendations
for fluoride supplements. It is important to weigh
in the risks and benefits of using systemic fluoride
supplements in infants and toddlers. Physicians
and dentists need to consider that there are two
well-established and accepted methods for caries
prevention in our communities: water fluoridation
and toothbrushing with fluoridated pastes or gels.
An infant or toddler who brushes at least once a
day receives a dose of systemic fluoride (43). Given
the increased risk of dental fluorosis that could re-
sult from the combined use of fluoridated denti-
frices and fluoride supplements, it is imperative
and ethically necessary that health professionals
consider the total exposure to fluoride in deciding
whether to recommend fluoride supplements.
Fluoride supplements should be targeted for
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infants and toddlers who, in the clinical opinion of
a health professional, are at risk of developing den-
tal caries. While the accuracy of the professional
assessment of caries risk has not yet been studied,
there is ample evidence that dental caries clusters
in families with low socioeconomic and education
status (44). Infants of mothers who are not con-
cerned about the sugar intake levels of their infants
should also be considered at high risk of develop-
ing dental caries (45). Mothers with a history of
caries development are more likely to infect their
children with cariogenic bacteria and put their
infants and toddlers at increased risk of developing
early childhood caries (46).
This analysis clearly shows that the use of fluo-
ride supplements increases the risk of developing
dental fluorosis. Though the severity of fluorosis in
the large majority of children is very mild, dentists
should inform the parents about the risks and ben-
efits that are associated with the use of fluoride
supplements. For many children, there may not be
a need for an additional application of fluoride. For
some children, the detrimental effect of a rampant
caries attack outweighs the risk of developing den-
tal fluorosis. For such children, an additional
source of fluoride (in the form of drops and tablets
that are chewed and swished in the mouth) may
be beneficial.
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